Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
The Cost-Effectiveness of Bosentan in the United Kingdom for Patients with Pulmonary Arterial Hypertension of WHO Functional Class III
Value in Health, 06/26/09
Stevenson M et al. - Bosentan is likely to be a more cost-effective first-line therapy for patients with PAH FC III in the UK than no active intervention.
Today in Economics of Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
2009 earnings survey: How do you compare
Medical Economics, 09/29/09
Physician pay cuts on horizon at Michigan Blues
American Medical News , 10/19/09
Medicare cracks down on false claims
Medical Economics, 11/02/09
Sponsor
Article Search
Sponsor